We know that every eye care professional has to deal with patients suffering from dry eye syndrome (DES). We've heard from many of you about how inadequate traditional artificial tears are and that even newer cyclosporin treatments are only effective in approximately 15% of dry eye syndrome sufferers. To answer this need we launch Hylashield^® over fifteen years ago, the first hyaluronan-based artificial tear. Now in its third generation, our HA based I-Drop^® continues to be the most reliable, effective and economical way to help treat the symptoms of dry eyes.